Eileen L. Yoon

490 EXTERNAL VALIDATION OF THE AAAPD-C RISK SCORE FOR PREDICTING HEPATOCELLULAR CARCINOMA AFTER HEPATITIS C CURE IN THE REAL-C COHORT

Xiang Yu Gao, Joanne K. Liu, Hidenori Toyoda, Manabu Morimoto et autres

490 EXTERNAL VALIDATION OF THE AAAPD-C RISK SCORE FOR PREDICTING HEPATOCELLULAR CARCINOMA AFTER HEPATITIS C CURE IN THE REAL-C COHORT

Xiang Yu Gao, Joanne K. Liu, Hidenori Toyoda, Manabu Morimoto et autres

Long‐Term Mortality Following Hepatitis C Cure in a Real‐World Multinational Cohort

Fanpu Ji, Sally Tran, Hidenori Toyoda, Masaru Enomoto et autres

BACKGROUND & AIMS: Direct-acting antiviral agents (DAA)-mediated HCV cure correlates with better outcomes, but there are insufficient data on detailed mortality-related risk factors after cure. This study sought to clarify mortality and associated risk factors post-HCV cure. METHODS: The study included HCV …

cn, us, jp, tw, sg, kr, ro, hk, es (code pays fourni par la source)

PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B

Ho Soo Chun, George Papatheodoridis, Minjong Lee, Hye Ah Lee et autres

Background & Aims Recent studies reported that moderate HBV DNA levels are significantly associated with hepatocellular carcinoma (HCC) risk in hepatitis B e antigen (HBeAg)-positive, non-cirrhotic patients with chronic hepatitis B (CHB). We aimed to develop and validate a new risk score …

kr, gr, pr, tr, it, es, nl, de (code pays fourni par la source)